Notice: This company has been marked as potentially delisted and may not be actively trading. Allena Pharmaceuticals (ALNA) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Allena Pharmaceuticals Inc ALNAQ Stock QuoteNovember 5, 2023 | morningstar.comAllena Pharmaceuticals Inc (ALNAQ)August 28, 2023 | investing.comSan Francisco Pharmaceuticals NewsMay 6, 2023 | bizjournals.comALNA.OSeptember 29, 2022 | reuters.comFirm Retention Summary: Allena Pharmaceuticals Inc.September 6, 2022 | wsj.comAllena Pharmaceuticals Shares Fall After Filing For BankruptcySeptember 6, 2022 | finance.yahoo.comTrading was temporarily halted for "ALNA" at 05:09 PM with a stated reason of "News pending."September 2, 2022 | marketbeat.comAllena Pharma Needs To Raise Capital To Continue As A Going ConcernAugust 11, 2022 | finance.yahoo.comAllena Pharmaceuticals Warns of Imminent Funding Need >ALNAAugust 11, 2022 | marketwatch.comTrading was temporarily halted for "ALNA" at 07:08 AM with a stated reason of "News pending."August 11, 2022 | marketbeat.comAllena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney DiseaseJuly 19, 2022 | finance.yahoo.comAllena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock SplitJuly 12, 2022 | finance.yahoo.comAllena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock SplitJuly 12, 2022 | finance.yahoo.comAllena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock SplitJuly 5, 2022 | apnews.comAllena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock SplitJuly 5, 2022 | finance.yahoo.comWhy Shares Of Allena Pharmaceuticals Are Skyrocketing TodayJuly 1, 2022 | uk.investing.comALNA Stock Alert: What to Know as Allena Pharmaceuticals Soars 200%June 29, 2022 | investorplace.comShort Volatility Alert: Allena PharmaceuticalsMay 16, 2022 | msn.comALNA Stock Alert: 5 Things to Know as Little-Known Allena Pharmaceuticals Soars 100%May 12, 2022 | investorplace.comNano cap stock Allena surges on heavy volumeMay 12, 2022 | seekingalpha.comAllena Pharmaceuticals $2.8M direct offeringMay 4, 2022 | seekingalpha.comAllena Pharmaceuticals Announces $2.8 Million Registered Direct OfferingMay 4, 2022 | finance.yahoo.comAllena Pharmaceuticals (NASDAQ:ALNA) Rating Increased to Hold at Zacks Investment ResearchZacks Investment Research raised shares of Allena Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Wednesday.March 23, 2022 | marketbeat.comAllena downgraded to Neutral at B. Riley citing the end to lead clinical programMarch 22, 2022 | seekingalpha.comWhy Are Allena Pharma Shares Plunging TodayMarch 21, 2022 | finance.yahoo.comAllena extends losses on plans to end trial for lead asset and financial concernsMarch 21, 2022 | seekingalpha.comTrading was temporarily halted for "ALNA" at 04:03 PM with a stated reason of "News pending."March 18, 2022 | marketbeat.comAllena Pharmaceuticals, Inc. (ALNA)March 1, 2022 | finance.yahoo.comAllena Pharmaceuticals, Inc.(ALNA)January 29, 2022 | fool.comAllena Pharmaceuticals (NASDAQ:ALNA) Lowered to "Hold" at Zacks Investment ResearchZacks Investment Research lowered shares of Allena Pharmaceuticals from a "buy" rating to a "hold" rating in a research report on Friday.January 14, 2022 | marketbeat.comWedbush Weighs in on Allena Pharmaceuticals, Inc.'s FY2021 Earnings (NASDAQ:ALNA)Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) - Investment analysts at Wedbush dropped their FY2021 EPS estimates for Allena Pharmaceuticals in a report released on Wednesday, January 5th. Wedbush analyst L. Moussatos now expects that the company will earn ($0.74) per share for the year, down from tJanuary 7, 2022 | marketbeat.comThinking about buying stock in Allena Pharmaceuticals, Carnival Corp, Oragenics, NLS Pharmaceutics, or BP?January 4, 2022 | morningstar.comAllena Stock Is Surging In Premarket Today As It Explores Strategic, Financing AlternativesJanuary 4, 2022 | finance.yahoo.comAllena Pharmaceuticals Provides Clinical and Corporate UpdateJanuary 4, 2022 | finance.yahoo.comAllena Pharmaceuticals (NASDAQ:ALNA) Stock Rating Upgraded by Zacks Investment ResearchZacks Investment Research raised Allena Pharmaceuticals from a "hold" rating to a "buy" rating and set a $0.75 price target on the stock in a report on Monday.December 27, 2021 | marketbeat.comAllena Pharmaceuticals (ALNA) Sees Hammer Chart Pattern: Time to Buy?November 22, 2021 | finance.yahoo.comAfter Plunging 19.7% in 4 Weeks, Here's Why the Trend Might Reverse for Allena Pharmaceuticals, Inc. (ALNA)November 22, 2021 | finance.yahoo.comAllena Pharmaceuticals, Inc. (ALNA) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowNovember 22, 2021 | finance.yahoo.comAllena Pharmaceuticals to Participate in the Stifel 2021 Virtual Healthcare ConferenceNovember 15, 2021 | finance.yahoo.comAllena Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Corporate ProgressNovember 10, 2021 | finance.yahoo.comAllena Pharmaceuticals Gets Fast Track Designation for Kidney Disease TreatmentNovember 3, 2021 | marketwatch.comAllena Pharmaceuticals Receives Fast Track Designation from FDA for the Development of ALLN-346 for Chronic Treatment of Hyperuricemia in Patients With Gout and Advanced Chronic Kidney DiseaseNovember 3, 2021 | finance.yahoo.comAllena Pharmaceuticals Commences Dosing of Gout Patients in Second Phase 2a Trial of ALLN-346September 29, 2021 | finance.yahoo.comAllena Pharmaceuticals to Participate in H.C. Wainwright’s 23rd Annual Global Investment ConferenceSeptember 9, 2021 | finance.yahoo.comAllena Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Corporate ProgressAugust 10, 2021 | finance.yahoo.com Get Allena Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Is Your 401(k) Safe? The Real Risk No One Sees Coming (Ad)Every day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopping, and the digital dollar is coming. You can protect yourself—but only if you act now. Don't wake up too late. Get your Digital Dollar Protection today and secure your retirement before the window closes. Click Here For Your Free Guide ALNA Media Mentions By Week ALNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALNA News Sentiment▼0.000.55▲Average Medical News Sentiment ALNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALNA Articles This Week▼00▲ALNA Articles Average Week Get Allena Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TRACON Pharmaceuticals News Today Eloxx Pharmaceuticals News Today Alvotech News Today VectivBio News Today aTyr Pharma News Today Ocugen News Today Amgen News Today Gilead Sciences News Today argenx News Today BioNTech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALNA) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allena Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allena Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
